脂质体吸入剂研究进展

Research on Liposome Inhalation

脂质体作为一类常见的代表性纳米制剂,具有较高的技术难度和行业准入壁垒,在高端制剂市场中所占比重较大。在抗病毒、抗超级细菌、抗真菌感染等领域,亟需开发吸入剂新品。开发和应用脂质体吸入剂核心技术对国内药企而言,既是重大的发展机遇,也是弯道超车提升产业水平的重要路径。在后新冠疫情时代如何在适合的赛道开发差异化的高端制剂,值得深思。

Liposomes,as a kind of common representative nano agents,have high technical difficulty and industry access barriers,and occupy a large proportion in the high-end pharmaceutical market.At the same time,inhalation pharmaceutical formulation in the field of anti-virus,anti-super-bacteria,fungal infection,also need to develop new products.The project development of dosage forms such as inhaled liposomes is also a major development opportunity for domestic pharmaceutical enterprises,and it is also an important way to improve their industrial level.It is worth pondering how to develop differentiated high-end complex pharmaceutical formulation in an appropriate way in the post COVID-19 epidemic era.